Michelle Nuno, PhD

Assistant Professor of Clinical Population and Public Health Sciences

Image of Michelle Nuno, PhD
Is this your profile? Click to edit


I am an Assistant Professor of Clinical Population and Public Health Sciences in the Division of Biostatistics at the University of Southern California. I received a B.S. in Applied Mathematics from the University of California, Riverside in 2015. I then went on to complete my graduate work at the University of California, Irvine, where I received an M.S in Statistics in 2017 and a Ph.D. in Statistics in 2020. My research interests include clinical trials and the development of robust statistical methodology for efficient sampling designs. I am particularly interested in biomedical applications in Alzheimer’s disease and pediatric oncology.


  • University of California, Irvine: Carl Cotman Young Investigator Award (UCI MIND), 2020
  • University of California, Irvine: Information and Computer Science Latino Excellence Award, 2019
  • University of California, Irvine: National Science Foundation Graduate Research Fellowship Program, 2017-2020
  • University of California, Irvine: Achievement Rewards for College Scientists Scholar, 2017-2019
  • University of California, Irvine: Robert L. Newcomb Memorial Endowed Graduate Student Award- UCI Statistics, 2016
  • University of California, Irvine: Eugene Cota Robles Fellowship, 2015-2020
  • University of California, Irvine: Provost Ph.D. Fellow, 2015


  • Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL JCO Oncol Pract. 2024 Jan 22; OP2300328. . View in PubMed
  • Characterizing Lymphovascular Invasion in Pediatric and Adolescent Malignant Ovarian Nongerminomatous Germ Cell Tumors: A Report from the Children’s Oncology Group J Pediatr Surg. 2023 Dec; 58(12):2399-2404. . View in PubMed
  • Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range Res Sq. 2023 Mar 21. . View in PubMed
  • Refining the serum miR-371a-3p test for viable germ cell tumor detection Sci Rep. 2023 06 29; 13(1):10558. . View in PubMed
  • Growth Hormone Deficiency in Childhood Intracranial Germ Cell Tumor Survivors J Endocrinol Metab. 2022 Jun; 12(3):79-88. . View in PubMed
  • A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis Clin Genitourin Cancer. 2021 12; 19(6):469-479. . View in PubMed
  • On the design of early-phase Alzheimer’s disease clinical trials with cerebrospinal fluid tau outcomes Clin Trials. 2021 12; 18(6):714-723. . View in PubMed
  • Censoring-robust time-dependent receiver operating characteristic curve estimators Stat Med. 2021 12 30; 40(30):6885-6899. . View in PubMed
  • Robust estimation in the nested case-control design under a misspecified covariate functional form Stat Med. 2021 01 30; 40(2):299-311. . View in PubMed
  • On the estimation in the nested case-control design under non-proportional hazards Scandinavian Journal of Statistics. 2020. . View in PubMed
  • Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials? Alzheimer Dis Assoc Disord. 2019 Apr-Jun; 33(2):104-112.. View in PubMed
  • Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer’s trials Alzheimers Res Ther. 2019 11 27; 11(1):92. . View in PubMed
  • More than skin deep: Major Histocompatibility Complex (MHC)-based attraction among Asian American speed-daters”. Evolution and Human Behavior. 2018; 39(4):447-456. . View in PubMed
  • Attitudes toward clinical trials across the Alzheimer’s disease spectrum Alzheimers Res Ther. 2017 Oct 04; 9(1):81. . View in PubMed
  • Handbook of statistics Alternative Sampling Designs for Time-to-Event Data with Applications to Biomarker Discovery in Alzheimer’s Disease. 2017; Vol 36:105-166. . View in PubMed
  • On a randomly accelerated particle Involvea Journal of Mathematics. 2016; 10(3):399-415. . View in PubMed